These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 19533434

  • 1. Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients.
    Ak G, Metintaş M, Yildirim H, Metintaş S, Dündar E, Erginel S, Alataş F.
    Tuberk Toraks; 2009; 57(1):22-31. PubMed ID: 19533434
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors in malignant pleural mesothelioma: role of talc pleurodesis.
    Al-Alao BS, Parissis H, Rychlik IJ, Graham A, McGuigan J.
    Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):443-9. PubMed ID: 22879552
    [Abstract] [Full Text] [Related]

  • 3. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
    Aydogmus U, Ozdemir S, Cansever L, Sonmezoglu Y, Kocaturk CI, Bedirhan MA.
    Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
    [Abstract] [Full Text] [Related]

  • 4. Pleurodesis outcome in malignant pleural mesothelioma.
    Fysh ET, Tan SK, Read CA, Lee F, McKenzie K, Olsen N, Weerasena I, Threlfall T, de Klerk N, Musk AW, Lee YC.
    Thorax; 2013 Jun; 68(6):594-6. PubMed ID: 23299964
    [Abstract] [Full Text] [Related]

  • 5. [Value of thoracoscopy and talc pleurodesis in diagnosis and palliative treatment of malignant pleural mesothelioma].
    Charvat JC, Brutsche M, Frey JG, Tschopp JM.
    Praxis (Bern 1994); 1998 Mar 04; 87(10):336-40. PubMed ID: 9545840
    [Abstract] [Full Text] [Related]

  • 6. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
    Aelony Y, Yao JF.
    Respirology; 2005 Nov 04; 10(5):649-55. PubMed ID: 16268920
    [Abstract] [Full Text] [Related]

  • 7. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P, Berruti A, Billé A, Lausi P, Levra MG, Giardino R, Ardissone F.
    Eur J Cardiothorac Surg; 2008 Feb 04; 33(2):307-13. PubMed ID: 18164622
    [Abstract] [Full Text] [Related]

  • 8. Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma.
    Chamberlain MH, Fareed K, Nakas A, Martin-Ucar AE, Waller DA.
    Eur J Cardiothorac Surg; 2008 Jul 04; 34(1):200-3. PubMed ID: 18450462
    [Abstract] [Full Text] [Related]

  • 9. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
    Lumachi F, Mazza F, Ermani M, Chiara GB, Basso SM.
    Anticancer Res; 2012 Nov 04; 32(11):5071-4. PubMed ID: 23155281
    [Abstract] [Full Text] [Related]

  • 10. [Long-term prognostic analysis of patients with malignant pleural mesothelioma].
    Cao KJ, Cui NJ.
    Ai Zheng; 2005 Jan 04; 24(1):72-5. PubMed ID: 15642204
    [Abstract] [Full Text] [Related]

  • 11. Can serum inflammatory parameters estimate outcome of pleurodesis in mesothelioma?
    Bilgin M, Hasdiraz L, Ozkaya M, Oguzkaya F.
    ANZ J Surg; 2007 Apr 04; 77(4):253-5. PubMed ID: 17388830
    [Abstract] [Full Text] [Related]

  • 12. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
    Yildirim H, Metintas M, Ak G, Metintas S, Erginel S.
    Lung Cancer; 2008 Oct 04; 62(1):139-44. PubMed ID: 18403045
    [Abstract] [Full Text] [Related]

  • 13. The pathology associated with therapeutic procedures in malignant mesothelioma.
    Attanoos RL, Gibbs AR.
    Histopathology; 2004 Oct 04; 45(4):393-7. PubMed ID: 15469478
    [Abstract] [Full Text] [Related]

  • 14. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S, Richards WG, Sugarbaker DJ.
    Int J Surg; 2008 Aug 04; 6(4):293-7. PubMed ID: 18585112
    [Abstract] [Full Text] [Related]

  • 15. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
    Rena O, Boldorini R, Papalia E, Mezzapelle R, Baietto G, Roncon A, Casadio C.
    Ann Thorac Surg; 2015 Apr 04; 99(4):1177-83. PubMed ID: 25669666
    [Abstract] [Full Text] [Related]

  • 16. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
    Stefani A, Natali P, Casali C, Morandi U.
    Eur J Cardiothorac Surg; 2006 Dec 04; 30(6):827-32. PubMed ID: 17113008
    [Abstract] [Full Text] [Related]

  • 17. Predictors of mortality within three months in the patients with malignant pleural effusion.
    Ozyurtkan MO, Balci AE, Cakmak M.
    Eur J Intern Med; 2010 Feb 04; 21(1):30-4. PubMed ID: 20122610
    [Abstract] [Full Text] [Related]

  • 18. Prevention of malignant seeding at drain sites after invasive procedures (surgery and/or thoracoscopy) by hypofractionated radiotherapy in patients with pleural mesothelioma.
    Di Salvo M, Gambaro G, Pagella S, Manfredda I, Casadio C, Krengli M.
    Acta Oncol; 2008 Feb 04; 47(6):1094-8. PubMed ID: 18770063
    [Abstract] [Full Text] [Related]

  • 19. Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma.
    Yan TD, Boyer M, Tin MM, Sim J, Kennedy C, McLean J, Bannon PG, McCaughan BC.
    Ann Thorac Surg; 2009 May 04; 87(5):1552-6. PubMed ID: 19379903
    [Abstract] [Full Text] [Related]

  • 20. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses.
    Steger V, Mika U, Toomes H, Walker T, Engel C, Kyriss T, Ziemer G, Friedel G.
    Ann Thorac Surg; 2007 Jun 04; 83(6):1940-5. PubMed ID: 17532375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.